What is ETHZ's earnings growth forecast for 2025-2025?
(NASDAQ: ETHZ) Ethzilla's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Ethzilla's earnings in 2025 is -$233,122,896.
In 2025, ETHZ is forecast to generate -$65,480,447 in earnings, with the lowest earnings forecast at -$62,912,587 and the highest earnings forecast at -$67,406,343.
What is ETHZ's revenue growth forecast for 2025-2025?
(NASDAQ: ETHZ) Ethzilla's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Ethzilla's revenue in 2025 is $4,110,169.
In 2025, ETHZ is forecast to generate $279,468,837 in revenue, with the lowest revenue forecast at $188,031,598 and the highest revenue forecast at $373,923,313.
What is ETHZ's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: ETHZ) forecast ROA is -6.49%, which is lower than the forecast US Biotechnology industry average of 7.08%.
What is ETHZ's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: ETHZ) Ethzilla's current Earnings Per Share (EPS) is -$159.75. In 2025, ETHZ's EPS is forecast to hit -$3.06 (min: -$2.94, max: -$3.15).
What is ETHZ's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: ETHZ) forecast ROE is -14.71%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.